HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The combined influence of immunotherapy and mite allergen reduction on bronchial hyperresponsiveness in mite-sensitive asthmatic children.

AbstractUNLABELLED:
Encasings for mattresses, blankets and pillows in combination with mite allergen reduction on the floor have proved effective in reducing bronchial hyperreactivity of mite-allergic children. We studied the effect of combining the use of encasings with specific immunotherapy in comparison to the use of encasings alone (control group). Twenty mite-allergic children (Skin Prick Test, RAST, mean age 10 years) with asthma and high domestic mite allergen exposure ( > 2 microg Der p 1 + f 1/g mattress dust) were included in our study. The concentration of these major allergens as well as specific and nonspecific bronchial hyperreactivity (PC20 FEV1 histamine) were assessed before, 6 months after and 1 year after start of treatment. All children received elongated polytetrafluorethylene (ePTFE; Goretex/Intervent Allergy Bedding System) encasings. A subgroup of eight children were treated additionally by specific immunotherapy with a partially purified mite extract (ALK Scherax) and a maximum dose of 100000 SQ-U Der p + f. Initially both groups were comparable with respect to the parameters assessed. In 80% of children, encasings reduced Der p 1 and Der f 1 concentrations on the mattress to below 3% of the initial values (P < 0.01). The median reduction was 99%. PC20 FEV1 histamine increased from 0.4 to 1.4 mg/dl (median) in the combined group with immunotherapy and encasings (P < 0.05) and remained essentially unchanged in the control group. PC20 FEV1 Der p did not increase significantly in either group.
CONCLUSION:
Specific immunotherapy with allergen extracts is an effective adjunct to encasings. Encasings, a key factor for reducing Der p 1 and Der f 1 on the mattress, should be used in combination with other avoidance measures (e.g. removal of carpets) in order to improve allergen-induced bronchial hyperreactivity.
AuthorsK Paul, U Klettke, U Wahn
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 157 Issue 2 Pg. 109-13 (Feb 1998) ISSN: 0340-6199 [Print] Germany
PMID9504783 (Publication Type: Journal Article)
Chemical References
  • Dust
  • Histamine
  • Polytetrafluoroethylene
Topics
  • Adolescent
  • Animals
  • Asthma (physiopathology)
  • Bedding and Linens
  • Bronchial Hyperreactivity (immunology, prevention & control)
  • Bronchial Provocation Tests
  • Child
  • Dust (adverse effects)
  • Environmental Exposure
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Histamine (analysis)
  • Humans
  • Hypersensitivity (immunology, prevention & control)
  • Immunotherapy
  • Male
  • Mites (immunology)
  • Polytetrafluoroethylene
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: